News

An ounce of prevention is worth a pound of cure. Are you up to date on your vaccines? 

Kidney disease is a risk factor for more severe complications of COVID-19, Respiratory Syncytial Virus (RSV) and the flu.  Respiratory Syncytial Virus (RSV) is a respiratory virus that infects the nose, throat and lungs. Complications from these infections can have serious health consequences and the treatment of these complications may require hospitalization. 

In August 2023, Health Canada approved a vaccine called Arexvy, for persons 60 years of age and older to prevent severe RSV infection. The Ontario Ministry of Health has now agreed to make it available urgently and free of charge to some high-risk populations including people who are 60 years of age and older who are receiving dialysis treatment or have had a kidney transplant. Speak to your renal team for more information about the vaccination roll out in your renal or transplant program. 

It is also recommended that everyone diagnosed with chronic kidney disease ensure that they receive the recommended doses of the COVID-19 vaccine boosters and flu vaccine. These viruses spread mainly in the fall and winter months, so it’s important to stay protected to reduce your risk.     

Please continue to protect yourself, whether you may be waiting for a vaccine or after vaccination, by continuing to follow all safety precautions, such as washing hands often and wearing a mask if you are sick.  If you have symptoms of any respiratory infection, contact your primary care provider or kidney care team as soon as possible. 

Source: https://www.ontario.ca/files/2023-12/moh-respiratory-syncytial-virus-fact-sheet-for-vaccine-recipients-v2.0-en-2023-12-18.pdf